To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Legislative Progress
Introduced
January 13, 2020
Latest Action
January 23, 2020
Primary Sponsor
Collin C. PetersonDemocratic(MN)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
67pct
10d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD. The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2021 · second_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: SENATE
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
2020 · fourth_quarter · Agriculture
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
2020 · fourth_quarter · Agriculture
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334), including H.R. 5587, regarding regulation of hemp-derived cannabidiol.
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $60,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.5587, To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020; FY2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.7610), FY2021 Consolidated Appropriations Act (H.R.7608); Implementation of H.R.6201, Families First Coronavirus Response Act (P.L.116-127); Implementation of H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; Implementation of H.R.266, Paycheck Protection Program and Health Care Enhancement Act (P.L.116-139); H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R. 133 Consolidated Appropriations Act. Include report language on CBD in the final appropriations measure that Congress passes during the lame duck session (or, in slightly different form as an amendment to a new stimulus package): H.R.5587 To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. Include language on CBD.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R. 133 Consolidated Appropriations Act. Include report language on CBD in the final appropriations measure that Congress passes during the lame duck session (or, in slightly different form as an amendment to a new stimulus package): H.R.5587 To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. Include language on CBD
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $146,000 · Firm income: Not reported
2020 · third_quarter · Agriculture
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334), including H.R. 5587, regarding regulation of hemp-derived cannabidiol.
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.5587, To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020; FY2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.7610), FY2021 Consolidated Appropriations Act (H.R.7608); Implementation of H.R.6201, Families First Coronavirus Response Act (P.L.116-127); Implementation of H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; Implementation of H.R.266, Paycheck Protection Program and Health Care Enhancement Act (P.L.116-139); H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $70,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · third_quarter · Health Issues
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Food Industry (safety, labeling, etc.)
COVID-19 Vaccine Prioritization; Pharmacist Scope of Practice COVID-19 supply chain issues H.R. 2117/S.3451 - the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act of 2019 H.R. 5415/S. 2958 - the Expanded Food Safety Investigation Act H.R. 3981 / S. 2337 - Food Date Labeling Act of 2019 H.R. 5861 - Agriculture Resilience Act - Title VII H.R. 6044 - the Accurate Labels Act H.R. 5587 - to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances
Client expense: $230,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, Treasury, Dept of, U.S. Mint, U.S. Trade Representative (USTR), White House Office
2020 · third_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $140,000 · Firm income: Not reported
2020 · third_quarter · Chemicals/Chemical Industry
HR 5587, To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol contained substances.
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2020 · third_quarter · Chemicals/Chemical Industry
H.R.5587 To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol and hemp derived cannabidiol contained substances
Client expense: Not reported · Firm income: $30,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2020 · third_quarter · Agriculture
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
2020 · third_quarter · Food Industry (safety, labeling, etc.)
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
2020 · second_quarter · Chemicals/Chemical Industry
H.R.5587 To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol and hemp derived cannabidiol contained substances
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Chemicals/Chemical Industry
H.R.5587 To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol and hemp derived cannabidiol contained substances
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Food Industry (safety, labeling, etc.)
Letter to White House on Food Industry Vaccine Prioritization H.R. 2117/S.3451 - the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act of 2019 H.R. 5415/S. 2958 - the Expanded Food Safety Investigation Act H.R. 3981 / S. 2337 - Food Date Labeling Act of 2019 H.R. 6044 - the Accurate Labels Act H.R. 5587 - to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances H.R. 2267 - the Infant Formula Protection Act H.R. 1769 - Defending Against Imitations and Replacements of Yogurt, Milk, and Cheese to Promote Regular Intake of Dairy Everyday Act or DAIRY PRIDE ACT H.R. 2827 - Keep Food Containers Safe From PFAS Act of 2019 H.R. 4487 - Codifying Useful Regulatory Definitions Act or the CURD ACT H.R. 5861 - Agriculture Resilience Act - Title VII
Client expense: $350,000 · Firm income: Not reported
2020 · second_quarter · Agriculture
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334), including H.R. 5587, regarding regulation of hemp-derived cannabidiol.
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $70,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · second_quarter · Chemicals/Chemical Industry
HR 5587, To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol contained substances.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Chemicals/Chemical Industry
H.R.5587 To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol and hemp derived cannabidiol contained substances
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · second_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $128,000 · Firm income: Not reported
2020 · second_quarter · Agriculture
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Food Industry (safety, labeling, etc.)
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Food Industry (safety, labeling, etc.)
H.R. 2117/S.3451 - the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act of 2019 H.R. 5415/S. 2958 - the Expanded Food Safety Investigation Act H.R. 3981 / S. 2337 - Food Date Labeling Act of 2019 H.R. 6044 - the Accurate Labels Act H.R. 5587 - to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances H.R. 2267 - the Infant Formula Protection Act H.R. 1769 - Defending Against Imitations and Replacements of Yogurt, Milk, and Cheese to Promote Regular Intake of Dairy Everyday Act or DAIRY PRIDE ACT H.R. 2827 - Keep Food Containers Safe From PFAS Act of 2019 H.R. 4487 - Codifying Useful Regulatory Definitions Act or the CURD ACT H.R. 5861 - Agriculture Resilience Act - Title VII
Client expense: $310,000 · Firm income: Not reported
2020 · first_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $165,000 · Firm income: Not reported
2020 · first_quarter · Health Issues
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Chemicals/Chemical Industry
H.R.5587 To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol and hemp derived cannabidiol contained substances
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Agriculture
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Food Industry (safety, labeling, etc.)
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Agriculture
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Food Industry (safety, labeling, etc.)
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: Not reported · Firm income: Not reported
| Republican |
| VA |
| Earl Blumenauer | Democratic | OR |
| Glenn Grothman | Republican | WI |
| James Comer | Republican | KY |
| Mark Pocan | Democratic | WI |
| Matt Gaetz | Republican | FL |
| Ron Kind | Democratic | WI |
| Salud O. Carbajal | Democratic | CA |
| TJ Cox | Democratic | CA |
| Thomas Massie | Republican | KY |
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
Government targets: Agriculture, Dept of (USDA), Federal Motor Carrier Safety Administration, Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), White House Office
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
Government targets: Federal Motor Carrier Safety Administration, HOUSE OF REPRESENTATIVES, SENATE
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of